Alkamax (1500 mg+250 mg)/5 ml (Oral Solution)

Title and Categories

• Alkamax Oral Solution
• Urinary Alkalinizing Agent

Color Options

• Clear liquid

Function

• Relieves discomfort in urinary tract infections
• Prevents kidney stone formation
• Prevents gout with uricosuric agent
• Alkalinizes urine without producing systemic alkalosis

Dosage and Administration

• Adults and children over 6 years: 10ml 3 times daily, diluted with 1 glass of water
• Children 1-6 years: 5ml 3 times daily, diluted with 1/2 glass of water
• Adults: 10-15ml 4 times daily (or as directed by the physician) diluted with 1 glass of water
• Pediatric: 5-10ml 4 times daily (or as directed by the physician) diluted with 1/2 glass of water

Interaction

• Concurrent administration of potassium-containing medication, potassium-sparing diuretics, ACE inhibitors, or cardiac glycosides may lead to toxicity

Contraindications

• Severe renal impairment with oliguria or azotemia
• Untreated Addison's disease
• Acute dehydration
• Severe myocardial damage
• Hyperkalemia from any cause

Side Effects

• Potassium intoxication causes listlessness, weakness, mental confusion, tingling of extremities, and other symptoms associated with a high concentration of potassium in the serum

Pregnancy and Lactation

• No information available regarding use during pregnancy and lactation

Precautions and Warnings

• Use with caution in patients with low urinary output
• Dilute adequately with water to minimize gastrointestinal injury
• Preferably take each dose after meals
• Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease

Overdose Effects

• Oral potassium salts rarely cause serious hyperkalemia in persons with normal excretory mechanisms
• If hyperkalemia occurs, immediate treatment measures include elimination of potassium-containing foods or medications, intravenous administration of dextrose solution with insulin, and the use of exchange resins, hemodialysis, or peritoneal dialysis

Therapeutic Class

• Prevention of repeated kidney stone formation
• Urinary Alkalinizing Agent

Storage Conditions

• Keep below 30°C temperature, away from light and moisture. Keep out of the reach of children

Related Brands

• Alcasol (1500 mg+250 mg)/5 ml (Oral Solution) - aci-limited
• Uri-K (1500 mg+250 mg)/5 ml (Oral Solution) - benham-pharmaceuticals-ltd
• Urifine (1500 mg+250 mg)/5 ml (Oral Solution) - novatek-pharmaceuticals-ltd
• Lyco (1500 mg+250 mg)/5 ml (Oral Solution) - alkad-laboratories
• Ureca (1500 mg+250 mg)/5 ml (Oral Solution) - general-pharmaceuticals-ltd